Concord Wealth Partners »

Harvard Bioscience shares owned by Concord Wealth Partners

Quarter-by-quarter ownership of Harvard Bioscience (HBIO) shares owned by Concord Wealth Partners from 13F filings

Historical chart of Concord Wealth Partners investment in Harvard Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Harvard Bioscience held by Concord Wealth Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harvard Bioscience by Concord Wealth Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0k 750 2.69
2024-03-31 $9.5k 2.3k 4.24

More positions owned by Concord Wealth Partners

Spdr Ser Tr Portfli Intrmdit (SPTI)
Spdr Ser Tr Portfolio Short (SPSB)
Ishares Tr Short Treas Bd (SHV)
NVIDIA Corporation (NVDA)
Spdr Ser Tr Portfolio Intrmd (SPIB)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ssga Active Tr Spdr Blackstone (HYBL)
Ishares Tr Core Div Grwth (DGRO)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Wisdomtree Tr Us Midcap Divid (DON)
Broadcom (AVGO)
Amazon (AMZN)
Dimensional Etf Trust Us Equity Market (DFUS)

View all positions for Concord Wealth Partners

Top funds holding Harvard Bioscience

BlackRock
Punch & Associates Investment Management
Harvey Partners
AMH Equity
Vanguard Group
Royce & Associates
Dimensional Fund Advisors
Granahan Investment Management
B. Riley Asset Management
Heartland Advisors
Boothbay Fund Management
Acadian Asset Management
Geode Capital Management
Meros Investment Management
State Street Corporation

View all funds holding Harvard Bioscience